The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention

Published:2023-01-29 Issue:3 Volume:23 Page:309-316
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Oh Mok¹,McBride Ali²^ORCID,Bhattacharjee Sandipan¹,Slack Marion¹³,Jeter Joanne⁴,Abraham Ivo³^ORCID

Affiliation:

1. Pharmacy Practice & Science Department, University of Arizona College of Pharmacy, Tucson, AZ, USA

2. The University of Arizona Cancer Center, North Campus, Tucson, AZ, USA

3. Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA

4. University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2169135

Reference30 articles.

1. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

2. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer

3. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

4. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

5. BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023;Expert Review of Pharmacoeconomics & Outcomes Research;2024-04-09

2. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Expert Review of Pharmacoeconomics & Outcomes Research;2023-12-21

3. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Journal of Medical Economics;2023-12-20

4. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Current Medical Research and Opinion;2023-12-20

5. What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends;ClinicoEconomics and Outcomes Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3